Endpoints News senior editor Amber Tong is leaving the biopharma news site for a new opportunity.
In addition to writing on the biggest scientific and business updates of the day, she steers coverage decisions for the newsroom and sets the agenda before the U.S. and Europe are awake. She has a particular focus on oncology, and how technologies developed for cancer are being used in other diseases.
Working out of Hong Kong, she has also helped bring attention to the growing role Asia plays on the global biopharma stage.
Tong is a graduate of Rice University, with a degree in anthropology.
